BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank64
5Y CAGR-44.4%
Year-over-Year Change
Year-over-year total asset growth rate
5Y CAGR
-44.4%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
3 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 4.84% |
| 2024 | -5.13% |
| 2023 | -6.01% |
| 2022 | -6.49% |
| 2021 | 75.72% |
| 2020 | 90.96% |
| 2019 | 19.37% |
| 2018 | -17.62% |
| 2017 | 98.40% |
| 2016 | -27.87% |